HCC827 ER1 (Q54881783)

From Wikidata

Jump to navigation Jump to search

cell line

HCC827-ER1
HCC 827 ER1
ER1

Language	Label	Description	Also known as
English	HCC827 ER1	cell line	HCC827-ER1 HCC 827 ER1 ER1

Statements

1 reference

Cellosaurus release 49

13 July 2024

cancer cell line

1 reference

Cellosaurus release 49

13 July 2024

parent cell line

1 reference

Cellosaurus release 49

13 July 2024

described by source

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

1 reference

Cellosaurus release 49

13 July 2024

Allosteric SHP2 inhibitor IACS-13909 overcomes EGFR-dependent and EGFR-independent resistance mechanisms towards osimertinib

1 reference

Cellosaurus release 49

13 July 2024

established from medical condition

adenocarcinoma of the lung

1 reference

Cellosaurus release 49

13 July 2024

derived from organism type

1 reference

Cellosaurus release 49

13 July 2024

Identifiers

1 reference

Cellosaurus release 49

13 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54881783&oldid=2258279931"